First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.
Saved in:
| Title: | First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease. |
|---|---|
| Authors: | Rizik DG; HonorHealth and the Scottsdale-Lincoln Health Network, Scottsdale, Arizona., Shah MG; HonorHealth, Scottsdale, Arizona., Burke RF; HonorHealth, Scottsdale, Arizona. |
| Source: | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2016 Nov 15; Vol. 88 (6), pp. 899-901. Date of Electronic Publication: 2016 Aug 22. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1522-726X |
|---|---|
| DOI: | 10.1002/ccd.26708 |
